
-
2010
Company Description
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company’s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion’s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Founders:
Melody Swartz -
Company Website:
-
Company E-mail:
-
Company Address:
EPFL Innovation Park, En Ruchoz ch. de la Dent d'Oche 1AEcublensSwitzerland -
CEO:
- Melody Swartz
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits